Holmes, Jeremy; Dunlop, David; Hemmett, Lindsay; … - In: PharmacoEconomics 22 (2004) 9, pp. 581-589
Background: Whilst lung cancer is the most common form of cancer in England and Wales (annual incidence rate of 50 per 100 Objective: To develop a model to assess the economics of second-line treatment of non-small cell lung cancer (NSCLC) from the perspective of the UK NHS, based on the...